✦ LIBER ✦

Valuing Pharma R&D: The Catch-22 of DCF

✍ Scribed by Ralph Villiger; Boris Bogdan

Book ID: 111354476
Publisher: John Wiley and Sons
Year: 2005
Weight: 163 KB
Volume: 17
Category: Article
ISSN: 1078-1196
DOI: 10.1111/j.1745-6622.2005.00039.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Value Of R&D

✍ BAUM, RUDY M. 📂 Article 📅 2011 🏛 American Chemical Society 🌐 English ⚖ 287 KB

The Catch-up Strategy of Petrobrás throu

The Catch-up Strategy of Petrobrás through Cooperative R&D

✍ André Tosi Furtado; Adriana Gomes de Freitas 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 106 KB

The catch 22 of condoms in US correction

The catch 22 of condoms in US correctional facilities

✍ Joseph D Tucker; Suzanne W Chang; Jacqueline P Tulsky 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 209 KB

The option value of advanced R & D

✍ Enrico Pennings; Onno Lint 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 876 KB

Existing tools for making R&D investment decisions cannot properly capture the option value in R&D. Since many new products are identified as failures during the R & D stages, the possibility of refraining from market introduction may add a significant value to the NPV of the R&D project. ]'his pape

When Pharma Merges, R&D Is the Dowry

✍ Agnew, B. 📂 Article 📅 2000 🏛 American Association for the Advancement of Scienc 🌐 English ⚖ 817 KB

The Social Value of Biodiversity for R&D

✍ Timo Goeschl; Timothy Swanson 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 189 KB